Press Releases

February 22, 2012 LUPIN announces settlement with SANTARUS and DEPOMED for GLUMETZA Patent Litigation

January 30, 2012 Lupin receives Tentative Approval for Generic Glumetza® Extended-Release Tablets

January 24, 2012 Strong Growth, Robust Operating Performance

December 30, 2011 US FDA clears Lupin’s Mandideep Facility

December 9, 2011 Lupin receives Tentative Approval for Generic Cymbalta® Delayed-release Capsules

December 2, 2011 Lupin receives FDA Approval for Generic SOLODYN® Tablets

November 17, 2011 Lupin Acquires I’rom Pharmaceuticals through its Japanese Subsidiary

November 9, 2011 Robust Growth, Record Profits Net Profit Up 24%, Q2 FY 2011-12

October 28, 2011 Lupin receives Final FDA Approval for Generic LoSeasonique® Tablets